Archives
Mitochondrial IRF3 in Bleomycin Lung Fibrosis
2026-09-29
The reference study identifies mitochondrial translocation of activated IRF3 as a mechanistic link between cGAS-STING signaling, defective mitophagy, ferroptosis, and pulmonary fibrosis. Its combination of mouse, epithelial-cell, biochemical, imaging, and flux-based assays provides a useful framework for dissecting how inflammatory signaling becomes mitochondrial injury.
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-09-29
This study shows that astrocytic GAT-3 is an active regulator of dentate gyrus synaptic transmission, linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-NMDAR activity, and contextual fear-memory formation. Its multimodal design provides a useful framework for studying neuron–astrocyte interactions while clarifying how pharmacological controls can distinguish transporter-mediated signaling from receptor-mediated GABA effects.
4-MUG for Lysosomal Enzyme Activity Assays
2026-09-28
4-MUG converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent readout suited to lysosomal disease models, enzyme kinetics, and screening. This practical guide connects assay design with recent GBA1 mRNA research while emphasizing calibration, workflow controls, and troubleshooting.
Exo1 for Exocytosis Assays: Workflow & Insights
2026-09-28
Exo1 offers an acute way to probe Golgi-to-ER traffic and distinguish ARF1-linked effects from some actions of Brefeldin A. This practical guide shows how to build a controlled exocytosis assay—and how to connect trafficking readouts to tumor extracellular-vesicle research without overstating what Exo1 has been shown to do.
15-PGDH Inhibition Supports Muscle Repair During Weight Loss
2026-09-27
A 2026 PNAS mouse study reports that inhibiting 15-PGDH improves muscle stem-cell activity, regenerated muscle-fiber growth, and strength recovery during semaglutide-associated weight loss. The findings suggest a potential way to address muscle-repair deficits while retaining weight-loss effects, but they do not establish clinical benefit or a human treatment strategy.
MLN4924 and CRL5–APC/C Crosstalk in Cancer
2026-09-26
MLN4924 is a selective NEDD8-activating enzyme inhibitor for probing how neddylation shapes ubiquitin-ligase activity. This article connects its broad pathway effects to emerging CRL5–APC/C crosstalk and shows how that distinction can sharpen cancer biology experiments.
Coumestrol in Cell Assays: A Practical Design Guide
2026-09-25
This scenario-driven guide shows how to plan viability, proliferation, and cytotoxicity experiments with Coumestrol (SKU C5832), while distinguishing receptor pharmacology from the higher-concentration effects reported in rheumatoid arthritis fibroblast-like synoviocytes. It covers assay interpretation, solution handling, vendor selection, and evidence-based limits.
GABAB Antagonism in Astrocyte–Neuron Research
2026-09-25
A translational framework for using CGP 55845 hydrochloride to test GABAB-dependent contributions to synaptic signaling—while keeping astrocytic GAT-3 mechanisms and their evidential limits distinct.
EGTA and Calcium Causality in Neural Assays
2026-09-24
EGTA (egtazic acid) helps researchers test whether calcium availability is necessary for a cellular response—not which channel produced it. This article connects selective chelation to the interpretation of neural electrophysiology, injury models, and practical assay design.
Wortmannin: From PI3K Mechanism to Translation
2026-09-24
A mechanistic and translational guide to using Wortmannin to interrogate PI3K signaling, cancer biology, and viral entry—while accounting for its irreversible action, kinase cross-reactivity, and experimental limits.
DiI (DiIC18(3)) Membrane Probe Workflow
2026-09-23
DiI (DiIC18(3)) labels lipid membranes with orange-red fluorescence, supporting membrane visualization, neuronal tracing, and selected cell-based assays. It is insoluble in water, so use an appropriate organic solvent and do not treat it as an aqueous stain or a selective intracellular-organelle marker.
Eimeria Infection, Sulfachlorpyridazine, and Cecal Omics
2026-09-23
The reference study integrates 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how Eimeria tenella infection and treatment reshape the chicken cecal environment. Its results distinguish the microbiota-stabilizing pattern associated with ethanamizuril from the reduction of potentially harmful Escherichia-Shigella linked to sulfachlorpyridazine, while showing limited effects from their low-dose combination.
Drug Repurposing for DNA Repair in CRISPR
2026-09-22
This study presents a large-scale screen of approved drugs to identify compounds that shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. Its findings connect repair-outcome engineering with synthetic lethality and provide a framework for validating pathway modulators in genome editing, disease modeling, and cancer research.
Erastin and Ferroptosis: Assay Logic Beyond Viability
2026-09-22
Erastin is a ferroptosis inducer best used as a mechanistic perturbation rather than a standalone viability reagent. This guide connects redox biology, RAS/BRAF genotype, and necroptosis-aware assay design to improve interpretation in ferroptosis research.
SETD7, White Adipose Browning, and Metabolic Health
2026-09-21
The reference study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis and links its depletion to an Adcy7–Sirt1–Creb1 signaling axis. Its mouse and adipocyte experiments suggest that selectively enhancing beige-fat function, rather than simply increasing adipogenesis, may improve energy expenditure and resistance to diet-induced metabolic dysfunction.